Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Minerva Neurosciences, Inc. Director's Dealing 2025

Dec 23, 2025

35086_dirs_2025-12-23_58ffd3a6-f6b6-4a68-b4ae-7d4a68e90a5e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Minerva Neurosciences, Inc. (NERV)
CIK: 0001598646
Period of Report: 2025-12-22

Reporting Person: Race Geoff (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-22 Employee Stock Option (right to buy) $3.98 A 1500000 Acquired 2035-12-21 Common Stock (1500000) Direct

Footnotes

F1: The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter.